What is the impact of blood-pressure control on cardiovascular events in patients with diabetic nephropathy?

被引：0
作者：
Mancia, G
机构：
[1] Univ Milan, Osped S Gerardo, Div Internal Med, I-20052 Monza, Italy
[2] Univ Milan, Osped S Gerardo, Dept Internal Med, I-20052 Monza, Italy
[3] Univ Milan, Dept Clin Med Prevent & Appl Biotechnol, Monza, Italy
来源：
NATURE CLINICAL PRACTICE NEPHROLOGY | 2006年 / 2卷 / 03期
关键词：
blood pressure; cardiovascular mortality; diabetic nephropathy; pulse pressure;
D O I：
10.1038/ncpneph0127
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 8 条
[1]   Impact of achieved blood pressure on cardiovascular outcomes in the irbesartan diabetic nephropathy trial [J].
Berl, T ;
Hunsicker, LG ;
Lewis, JB ;
Pfeffer, MA ;
Porush, JG ;
Rouleau, JL ;
Drury, PL ;
Esmatjes, E ;
Hricik, D ;
Pohl, M ;
Raz, I ;
Vanhille, P ;
Wiegmann, TB ;
Wolfe, BM ;
Locatelli, F ;
Goldhaber, SZ ;
Lewis, EJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2170-2179
[2]   Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy [J].
Berl, T ;
Hunsicker, LG ;
Lewis, JB ;
Pfeffer, MA ;
Porush, JG ;
Rouleau, JL ;
Drury, PL ;
Esmatjes, E ;
Hricik, D ;
Parikh, CR ;
Raz, I ;
Vanhille, P ;
Wiegmann, TB ;
Wolfe, BM ;
Locatelli, F ;
Goldhaber, SZ ;
Lewis, EJ .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (07) :542-549
[3]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[4]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[5]   2003 European society of hypertension -: European Society of Cardiology guidelines for the management of arterial hypertension [J].
Mancia, G ;
Rosei, EA ;
Cifkova, R ;
DeBacker, G ;
Erdine, S ;
Fagard, R ;
Farsang, C ;
Heagerty, AM ;
Kawecka-Jaszcs, K ;
Kiowski, W ;
Kjeldsen, S ;
Lüscher, T ;
McInnes, G ;
Mallion, JM ;
Brien, EO ;
Poulter, NR ;
Priori, SG ;
Rahn, KH ;
Rodicio, JL ;
Ruilope, LM ;
Safar, M ;
Staessen, JA ;
van Zwieten, P ;
Waeber, B ;
Williams, B ;
Zanchetti, A ;
Zannad, F .
JOURNAL OF HYPERTENSION, 2003, 21 (06) :1011-1053
[6]   Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension - The systolic hypertension in the elderly program [J].
Savage, PJ ;
Pressel, SL ;
Curb, JD ;
Schron, EB ;
Applegate, WB ;
Black, HR ;
Cohen, J ;
Davis, BR ;
Frost, P ;
Smith, W ;
Gonzalez, N ;
Guthrie, GP ;
Oberman, A ;
Rutan, G ;
Probstfield, JL ;
Stamler, J .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (07) :741-751
[7]  
Stearne MR, 1998, BMJ-BRIT MED J, V317, P703
[8]  
Turnbull F, 2005, ARCH INTERN MED, V165, P1410
1